2m 2m 2m 2m 2m 2m 2m
GINKGO BIO-A (DNA)
NYSE
$8.82-$0.04 (-0.51%)
Price as of Jun 23, 2026 7:32 PM EDT- $482.4MMarket Cap
- -3.59%1-Year Change
- BiotechnologyIndustry
GINKGO BIO-A (DNA)
$8.82-$0.04 (-0.51%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 132.7M -41.53% | 227.0M -9.71% | 251.5M -47.36% | 477.7M +52.21% | |
Cost of Revenue | 31.5M -64.62% | 89.1M -17.51% | 108.0M -47.11% | 204.2M +57.46% | |
Gross Profit | 101.2M -26.62% | 137.9M -3.83% | 143.4M -47.55% | 273.5M +48.52% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | 168.6M N/A | |
Research and Development Expense | -243.8M -42.51% | -424.1M -26.96% | -580.6M -44.84% | -1.1B -8.44% | |
Depreciation and Amortization Expense | 59.0M -6.39% | 63.0M -10.62% | 70.5M +65.70% | 42.6M +46.35% | |
Total Operating Expenses | 485.4M -38.30% | 786.8M -29.49% | 1.1B -58.47% | 2.7B +25.41% | |
Operating Profit | -315.3M -43.68% | -559.8M -35.24% | -864.4M -60.87% | -2.2B +20.81% | |
Interest Income | 22.6M -41.43% | 38.6M -32.52% | 57.2M +182.39% | 20.3M +2,320.79% | |
Interest Expense | N/A N/A | N/A N/A | -93,000 -12.26% | -106,000 -95.53% | |
Interest Income and Expense and Net | 22.6M -41.43% | 38.6M -32.41% | 57.1M +183.41% | 20.2M +1,412.24% | |
Total Nonoperating Income and Expense | 1.7M -86.30% | 12.2M +142.93% | -28.5M -132.59% | 87.6M +1,006.82% | |
Income before Taxes | -313.6M -42.72% | -547.5M -38.68% | -892.9M -57.91% | -2.1B +15.41% | |
Income Taxes | -837,000 +74.74% | -479,000 +574.65% | -71,000 -99.53% | -15.0M +915.34% | |
Extraordinary Items | 0 -100.00% | 4.8M -96.03% | 121.4M +1,102.02% | 10.1M N/A | |
Net Income | -312.8M -42.83% | -547.0M -38.73% | -892.9M -57.58% | -2.1B +15.02% | |
Net Income from Continuing Operations Applicable to Common | -313.6M -42.72% | -547.5M -38.68% | -892.9M -57.91% | -2.1B +15.41% | |
Basic EPS and Net Income | -5.64 -46.49% | -10.54 +2,191.30% | -0.46 -63.20% | -1.25 -7.41% | |
Diluted EPS and Net Income | -5.64 -46.49% | -10.54 +2,191.30% | -0.46 -63.20% | -1.25 -10.07% | |
Basic Weighted Average Shares | 55.5M +6.87% | 51.9M -97.33% | 1.9B +15.80% | 1.7B +23.47% | |
Diluted Weighted Average Shares | 55.5M +6.87% | 51.9M -97.33% | 1.9B +15.75% | 1.7B +23.48% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 167.2M -70.23% | 561.6M -40.52% | 944.1M -28.25% | 1.3B -15.11% | |
Short-Term Investments | 255.4M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 422.6M -24.74% | 561.6M -40.52% | 944.1M -28.25% | 1.3B -15.11% | |
Total Current Assets | 471.8M -21.72% | 602.7M -39.83% | 1.0B -30.92% | 1.5B -15.84% | |
Accumulated Depreciation | 190.6M +18.48% | 160.9M +33.26% | 120.7M +30.15% | 92.8M +51.93% | |
Property and Plant and Equipment and Net | 167.8M -17.64% | 203.7M +8.25% | 188.2M -40.21% | 314.8M +115.94% | |
Total Long-Term Assets | 47.2M -14.76% | 55.3M -4.68% | 58.1M -34.57% | 88.7M +101.69% | |
Total Assets | 1.1B -18.71% | 1.4B -17.29% | 1.7B -34.42% | 2.5B +22.61% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 10.3M -17.54% | |
Total Current Liabilities | 96.0M -10.53% | 107.3M -34.54% | 163.9M -5.26% | 173.0M +28.35% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 131.2M -11.55% | |
Total Long-Term Liabilities | 22.9M +38.01% | 16.6M -11.51% | 18.7M -39.94% | 31.2M -13.34% | |
Total Liabilities | 611.1M -7.60% | 661.4M +16.40% | 568.2M -29.25% | 803.0M +59.46% | |
Retained Earnings | -6.2B +5.36% | -5.8B +10.34% | -5.3B +20.30% | -4.4B +91.38% | |
Total Stockholders Equity | 508.6M -28.97% | 716.1M -34.73% | 1.1B -36.81% | 1.7B +15.34% | |
Total Shares Outstanding | 58.2M +7.07% | 54.4M -97.28% | 2.0B +5.78% | 1.9B +17.41% | |
Cash Flow | |||||
Cash from Operating Activities | -171.1M -46.47% | -319.6M +8.15% | -295.5M +17.17% | -252.2M -0.64% | |
Capital Expenditures | 7.7M -87.74% | 62.5M +53.28% | 40.8M -21.94% | 52.3M -7.52% | |
Cash from Investing Activities | -240.3M +286.09% | -62.2M -22.87% | -80.7M +19.73% | -67.4M -8.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 17.8M +1,122.14% | -1.7M -45.93% | -3.2M -103.37% | 95.3M -93.79% | |
Financials Ratio | |||||
Gross Margin | 76.25% +25.51% | 60.76% +6.51% | 57.05% -0.36% | 57.25% N/A | |
Operating Margin | -237.50% -3.67% | -246.54% -28.28% | -343.76% -25.66% | -462.41% N/A | |
Return on Assets | -25.05% -30.33% | -35.96% -15.34% | -42.47% -53.49% | -91.31% N/A | |
Return on Equity | -51.08% -15.35% | -60.34% -4.26% | -63.02% -51.47% | -129.87% N/A | |
Revenue Growth | -41.53% +327.81% | -9.71% -79.50% | -47.36% -190.71% | 52.21% N/A | |
Current Ratio | 4.92 -12.51% | 5.62 -8.08% | 6.11 -27.08% | 8.38 N/A | |
Cash Ratio | 1.74 -66.72% | 5.24 -9.13% | 5.76 -24.26% | 7.61 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.08 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.06 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow